MPM BioImpact Innovations Equities Master, LP — Form D/A
MPM BioImpact Innovations Equities Master, LP of BOSTON, MA, a pooled investment fund, filed a Form D amendment with the SEC on 2025-06-27. $131.1M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2025-06-27
- Form: D/A
- Accession: 0000929638-25-002339
- Industry: Pooled Investment Fund
- Exemptions: 3C.7, 06b, 3C
- Amount sold: $131.1M
- Investors: 7
- Date of first sale: 2024-06-03
- Security types: fund interests
- SEC file number: 021-517266
Issuer
- Name: MPM BioImpact Innovations Equities Master, LP
- CIK: 0002028760
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 399 BOYLSTON STREET, SUITE 1100, BOSTON, MA, 02116
- Phone: 617-425-9200
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Christiana Goh Bardon | Executive Officer | Boston, MA |
| Kristen Goh Laguerre | Executive Officer | Boston, MA |
| n/a MPM BioImpact Innovations Equities GP, LLC | Executive Officer | Boston, MA |
| Christopher Goh Wolf | Executive Officer | Boston, MA |
| Christiana Goh Bardon | Related Person | Boston, MA |
| Kristen Laguerre | Related Person | Boston, MA |
| Christopher Wolf | Related Person | Boston, MA |
Other filings by this issuer (2)
More